Economic analysis of nutrition interventions for chronic disease prevention: Methods, research, and policy

Nutrition Reviews

Volumn 69, Issue 9, 2011, Pages 533-549

  Wong, John B ^a   Coates, Paul M ^b   Russell, Robert M ^b   Dwyer, Johanna T ^b,c   Schuttinga, James A ^b   Bowman, Barbara A ^d   Peterson, Sarah A ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Cost benefit analysis; Medical economics; Nutrition policy; Nutrition therapy; Primary prevention

Indexed keywords

AGING; AGRICULTURE; ARTICLE; CANADA; CHILD HEALTH; CHRONIC DISEASE; CLINICAL PRACTICE; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE CONTROL; ECONOMIC EVALUATION; FOOD AND DRUG ADMINISTRATION; FUNDING; GERMANY; GOVERNMENT; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH SERVICE; HISTORY OF MEDICINE; HUMAN; INTERNATIONAL COOPERATION; INTERPERSONAL COMMUNICATION; MEDICAID; MEDICAL RESEARCH; MEDICARE; NATIONAL HEALTH ORGANIZATION; PRACTICE GUIDELINE; QUALITY OF LIFE; REIMBURSEMENT; SENSITIVITY ANALYSIS; UNCERTAINTY; UNITED KINGDOM; UNITED STATES;

CHRONIC DISEASE; DIET; HEALTH PROMOTION; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); NUTRITION POLICY; PRACTICE GUIDELINES AS TOPIC; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 80052371946     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2011.00412.x     Document Type: Article

References (54)

1. Hartman M, Martin A, Nuccio O, Catlin A, National Health Expenditure Accounts Team. Health spending growth at a historic low in 2008. Health Aff. 2010;29:147-155.
2. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes, 3rd ed. Oxford: Oxford University Press; 2005.
3. Kaplan RM. The significance of quality of life in health care. Qual Life Res. 2003;12(Suppl 1):3-16.
4. Lipscomb J, Yabroff KR, Brown ML, Lawrence W, Barnett PG. Health care costing: data, methods, current applications. Med Care. 2009;47(Suppl 1):S1-S6.
5. Meltzer D. Addressing uncertainty in medical cost-effectiveness analysis implications of expected utility maximization for methods to perform sensitivity analysis and the use of cost-effectiveness analysis to set priorities for medical research. J Health Econ. 2001;20:109-129.
6. Groot Koerkamp B, Weinstein MC, Stijnen T, Heijenbrok-Kal MH, Hunink MGM. Uncertainty and patient heterogeneity in medical decision models. Med Decis Making. 2010;30:194-205.
7. Committee to Evaluate Measures of Health Benefits for Environmental Health and Safety Regulation, ed. Valuing Health for Regulatory Cost-Effectiveness Analysis. Washington, DC: The National Academies Press; 2006.
8. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford; 1996.
9. Chambers JD, Neumann PJ, Buxton MJ. Does Medicare have an implicit cost-effectiveness threshold? Med Decis Making. 2010;30:E14-E27.
10. Marmor T, Oberlander J, White J. The Obama administration's options for health care cost control: hope versus reality. Ann Intern Med. 2009;150:485-489.
11. Office of Dietary Supplements. Strategic Plan 2010-2014. Bethesda, MD: Office of Dietary Supplements, National Institutes of Health, U.S. Department of Health & Human Services. 2010. NIH Publication Number 10-7527.
12. Huang H-Y, Caballero B, Chang S, etal. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann Intern Med. 2006;145:372-385.
13. Lippman SM, Klein EA, Goodman PJ, etal. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39-51.
14. Gaziano JM, Glynn RJ, Christen WG, etal. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2009;301:52-62.
15. Neumann PJ, Fang C-H, Cohen JT. 30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvement. Pharmacoeconomics. 2009;27:861-872.
16. Avenell A, Campbell MK, Cook JA, etal. Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomised, double blind, placebo controlled trial. BMJ. 2005;331:324-329.
17. Kilonzo MM, Vale LD, Cook JA, etal. A cost-utility analysis of multivitamin and multimineral supplements in men and women aged 65 years and over. Clin Nutr. 2007;26:364-370.
18. Tice JA, Ross E, Coxson PG, etal. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond. JAMA. 2001;286:936-943.
19. Bentley TG, Weinstein MC, Willett WC, Kuntz KM. A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr. 2009;12:455-467.
20. Schmier JK, Rachman NJ, Halpern MT. The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events. Manag Care. 2006;15:43-50.
21. Fuhr JP Jr, He H, Goldfarb N, Nash DB. Use of chromium picolinate and biotin in the management of type 2 diabetes: an economic analysis. Dis Manag. 2005;8:265-275.
22. Franzosi MG, Brunetti M, Marchioli R, etal. Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial. Pharmacoeconomics. 2001;19:411-420.
23. Lamotte M, Annemans L, Kawalec P, Zoellner Y. A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction. Pharmacoeconomics. 2006;24:783-795.
24. Quilici S, Martin M, McGuire A, Zoellner Y. A cost-effectiveness analysis of n-3 PUFA (Omacor) treatment in post-MI patients. Int J Clin Pract. 2006;60:922-932.
25. Stevenson M, Lloyd-Jones M, Papaioannou D. Vitamin K to prevent fractures in older women: systematic review and economic evaluation. Health Technol Assess. 2009;13:iii-ixi; 1-134.
26. Trevithick JR, Massel D, Robertson JM, etal. Modeling savings from prophylactic REACT antioxidant use among a cohort initially aged 50-55 years: a Canadian perspective. J Orthomol Med. 2006;21:212-220.
27. Nasser S, Vestenbaek U, Beriot-Mathiot A, Poulsen PB. Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma. Allergy. 2008;63:1624-1629.
28. Hoddinott J, Maluccio JA, Behrman JR, Flores R, Martorell R. Effect of a nutrition intervention during early childhood on economic productivity in Guatemalan adults. Lancet. 2008;371:411-416.
29. Fernald LC, Gertler PJ, Hou X. Cash component of conditional cash transfer program is associated with higher body mass index and blood pressure in adults. J Nutr. 2008;138:2250-2257.
30. Avendano M, Glymour MM, Banks J, Mackenbach JP. Health disadvantage in US adults aged 50 to 74 years: a comparison of the health of rich and poor Americans with that of Europeans. Am J Public Health. 2009;99:540-548.
31. Banks J, Marmot M, Oldfield Z, Smith JP. Disease and disadvantage in the United States and in England. JAMA. 2006;295:2037-2045.
32. Lee R, Lee S-H, Mason A. Charting the economic lifecycle. In: Prskawetz A, Bloom DE, Lutz W, eds. Population Aging, Human Capital Accumulation, and Productivity Growth, A Supplement to Population and Development Review 33. New York: Population Council; 2008:208-237.
33. Grosse SD, Waitzman NJ, Romano PS, Mulinare J. Re-evaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health. Am J Public Health. 2005;95:1917-1922.
34. Tilford JM, Grosse SD, Goodman AC, Li K. Labor market productivity costs for caregivers of children with spina bifida: a population-based analysis. Med Decis Making. 2009;29:23-32.
35. Llanos A, Hertrampf E, Cortes C, Pardo A, Grosse SD, Uauy R. Cost-effectiveness of a folic acid fortification program in Chile. Health Policy. 2007;83:295-303.
36. Grosse SD, Ouyang L, Collins JS, Green D, Dean JH, Stevenson RE. Economic evaluation of a neural tube defect recurrence prevention program. Am J Prev Med. 2008;35:572-577.
37. Rein DB, Saaddine JB, Wittenborn JS, etal. Cost-effectiveness of vitamin therapy for age-related macular degeneration. Ophthalmology. 2007;114:1319-1326.
38. Eisenberg JM. Clinical economics: a guide to the economic analysis of clinical practices. JAMA. 1989;262:2879-2886.
39. Agency for Healthcare Research and Quality. Cost-effectiveness of DNA Stool Testing to Screen for Colorectal Cancer. Rockville, MD: Agency for Healthcare Research and Quality. 2007:Available at: Accessed 15 June 2010.
40. Agency for Healthcare Research and Quality. Cost-effectiveness of CT Colonography to Screen for Colorectal Cancer. Rockville, MD: Agency for Healthcare Research and Quality. 2009:Available at: Accessed 15 June 2010.
41. Yabroff KR, Brown ML, Lawrence WF, Barnett PG, Lipscomb J, eds. Health care costing: data, methods, future directions. Med Care. 2009;47(Suppl 1):S127-S142.
42. Dong D, Lin B-H. Fruit and Vegetable Consumption by Low-Income Americans: Would a Price Reduction Make a Difference? Washington, DC: U.S. Department of Agriculture. ERR-70. 2009:Available at: Accessed 30 June 2010.
43. Dong D, Leibtag E. Promoting Fruit and Vegetable Consumption: Are Coupons More Effective than Pure Price Discounts? Washington, DC: U.S. Department of Agriculture. ERR-96. 2010:Available at: Accessed 30 June 2010.
44. Lin B-H, Smith TA, Lee J-Y. The Effects of a Sugar-Sweetened Beverage Tax: Consumption, Calorie Intake, Obesity, and Tax Burden by Income. Paper presented at: Agricultural & Applied Economics Association Meeting. Denver, CO. 2010:Available at: Accessed 15 June 2010.
45. Ver Ploeg M. WIC and the Battle against Childhood Overweight. Economic Brief Number 13; April 2007. Available at: Accessed 30 June 2010.
46. Ver Ploeg M, Ralston K. Food Stamps and Obesity: What Do We Know? Washington, DC: U.S. Department of Agriculture. EIB-34. 2008:Available at: Accessed 30 June 2010.
47. Newman C, Guthrie J, Mancino L, Ralston K, Musiker M. Meeting Total Fat Requirements for School Lunches: Influence of School Policies and Characteristics. Washington, DC: U.S. Department of Agriculture. ERR-87. 2009:Available at: Accessed 30 June 2010.
48. Ver Ploeg M, Breneman V, Farrigan T, etal. Access to Affordable and Nutritious Food - Measuring and Understanding Food Deserts and Their Consequences: Report to Congress. Washington, DC: U.S. Department of Agriculture. AP-036. 2009. Available at: Accessed 30 June 2010.
49. Just DR, Mancino L, Wansink B. Could Behavioral Economics Help Improve Diet Quality for Nutrition Assistance Program Participants? Washington, DC: U.S. Department of Agriculture. ERR-43. 2007:Available at: Accessed 30 June 2010.
50. Guyatt GH, Oxman AD, Vist GE, etal. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-926.
51. Drummond MF, Schwartz JS, Jönsson B, etal. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244-258.
52. Serumaga B, Ross-Degnan D, Avery AJ, Elliott RA, Majumdar SR, Zhang F, Soumerai SB. Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. BMJ. 2011;342:d108.
53. Walley T, Mrazek M, Mossialos E. Regulating pharmaceutical markets: improving efficiency and controlling costs in the UK. Int J Health Plan Manage. 2005;20:375-398.
54. Schwarzer R, Siebert U. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden. Int J Technol Assess Health Care. 2009;25:305-314.